Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170,900 | 123,200 | 107,300 | 133,900 | 152,600 |
| Receivables | 359,100 | 367,200 | 377,000 | 339,700 | 372,600 |
| Inventories | 309,400 | 297,500 | 284,200 | 307,600 | 294,700 |
| Income taxes - deferred | 35,100 | 34,100 | 31,700 | 27,400 | 31,400 |
| Other current assets | 21,900 | 31,500 | 21,600 | 26,200 | 25,000 |
| TOTAL | $896,400 | $853,500 | $821,800 | $834,800 | $876,300 |
| Non-Current Assets | |||||
| PPE Net | 1,110,700 | 1,113,300 | 1,101,500 | 1,121,400 | 1,114,600 |
| Intangibles | 630,700 | 641,500 | 634,700 | 650,400 | 662,700 |
| Other Non-Current Assets | 170,300 | 168,100 | 164,700 | 160,600 | 163,800 |
| TOTAL | $1,911,700 | $1,922,900 | $1,900,900 | $1,932,400 | $1,941,100 |
| Total Assets | $2,808,100 | $2,776,400 | $2,722,700 | $2,767,200 | $2,817,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,500 | 1,500 | 1,500 | 1,200 | 3,000 |
| Accounts payable and accrued liabilities | 179,100 | 166,500 | 177,900 | 172,400 | 172,700 |
| Accrued Expenses | 160,300 | 156,400 | 156,200 | 184,600 | 186,600 |
| TOTAL | $350,500 | $333,100 | $345,600 | $366,900 | $376,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 740,100 | 740,300 | 740,400 | 741,700 | 716,700 |
| Other Non-Current Liabilities | 385,400 | 401,300 | 407,400 | 416,200 | 357,200 |
| TOTAL | $1,160,000 | $1,174,100 | $1,177,400 | $1,189,300 | $1,111,800 |
| Total Liabilities | $1,510,500 | $1,507,200 | $1,523,000 | $1,556,200 | $1,488,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,554 | 71,457 | 71,397 | 71,282 | 72,074 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 1,829,300 | 1,778,900 | 1,733,100 | 1,699,600 | 1,737,900 |
| Other shareholders' equity | -54,400 | -25,500 | -42,900 | 13,200 | 47,100 |
| TOTAL | $1,297,600 | $1,269,200 | $1,199,700 | $1,211,000 | $1,329,100 |
| Total Liabilities And Equity | $2,808,100 | $2,776,400 | $2,722,700 | $2,767,200 | $2,817,400 |